In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
A large U.S. health records study suggests that difficulty seeing blood in urine may put color-blind patients at higher risk.
MedPage Today on MSN
Color blindness and bladder cancer: A bad combination for survival?
People with color vision deficiency -- commonly known as color blindness -- may have a higher risk of mortality from bladder ...
Inlexzo is a new treatment for a type of bladder cancer in adults that hasn’t spread to the muscles and doesn’t respond to Bacillus Calmette-Guérin (BCG) therapy. It’s approved for treating non-muscle ...
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the activation of the NRG Oncology trial, ARCHER (NRG-GU015), a ...
Most people worry about cancer at some point, but knowing which symptoms actually warrant immediate medical attention can be life-saving. While many health issues cause similar symptoms, certain ...
BERLIN October 20, 2025 – Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the cancer benefit from immunotherapy with atezolizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback